共 251 条
[1]
Slamon DJ(1987)Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 235 177-182
[2]
Clark GM(1989)Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer Science 244 707-712
[3]
Wong SG(2000)The molecular and cellular biology of HER2/neu gene amplification/overexpression and the clinical development of herceptin (trastuzumab) therapy for breast cancer Cancer Treat Res 103 57-75
[4]
Levin WJ(1992)Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up J Clin Oncol 10 1044-1048
[5]
Ullrich A(1996)Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer J Clin Oncol 14 737-744
[6]
McGuire WL(1999)Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease J Clin Oncol 17 2639-2648
[7]
Slamon DJ(2002)Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer J Clin Oncol 20 719-726
[8]
Godolphin W(1998)Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment J Clin Oncol 16 2659-2671
[9]
Jones LA(2005)Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group J Clin Oncol 23 4265-4274
[10]
Holt JA(2001)Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 N Engl J Med 344 783-792